astrazeneca aims for $80 bln in total revenue by 2030 | reuters
Published 3 months ago • 745 plays • Length 1:04Download video MP4
Download video MP3
Similar videos
-
1:14
astrazeneca vaccine turns profitable
-
1:14
astrazeneca shares dip after $39 bln alexion deal
-
1:14:17
live: who experts to issue recommendations on astrazeneca vaccine
-
2:47
astrazeneca vaccine deemed ‘safe and effective’ by ema
-
1:29
astrazeneca reports vaccine sales of $275 million
-
6:18
blood clots, fda approval, and the astrazeneca covid vaccine
-
8:19
why insulin is so expensive | so expensive
-
11:20
the covid-19 vaccines from johnson & johnson and astrazeneca: what's in them and how do they work?
-
3:44
astrazeneca to buy alexion pharmaceuticals in $39 billion deal
-
2:37
'dramatic' 80pc drop in nsw's covid-19 astrazeneca vaccinations among health workers | abc news
-
4:31
astrazeneca's coronavirus vaccine found to be 79% effective with no increased risk of blood clotting
-
1:51
astrazeneca report says vaccine 76% effective
-
3:59
covid-19: single astrazeneca or pfizer dose 80% effective at preventing hospitalisations in over 80s
-
2:29
astrazeneca's two-dose vaccine nearly 80-percent effective in u.s. trials
-
2:27
astrazeneca vaccine found to be 79% effective in u.s. trial
-
5:31
study suggests oxford-astrazeneca vaccine effective in over-80s| covid-19 vaccine| latest world news
-
10:57
er doctor discusses astrazeneca's covid-19 vaccine and a new antibody treatment
-
0:52
astrazeneca covid vaccine cleared for emergency use by who
-
3:05
astrazeneca vaccine found to be 79% effective in u.s. study
-
1:39
astrazeneca and u.s. strike deal to develop covid-19 antibody drug supply
-
3:44
astrazeneca - 2018 heroes of chemistry
-
1:22
astrazeneca starts trials of virus treatment